Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens
Top Cited Papers
Open Access
- 12 September 2009
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 390 (3) , 404-409
- https://doi.org/10.1016/j.bbrc.2009.09.029
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Cross-Reactive Human IgM-Derived Monoclonal Antibodies that Bind to HIV-1 Envelope GlycoproteinsViruses, 2010
- Analysis of somatic hypermutation in X-linked hyper-IgM syndrome shows specific deficiencies in mutational targetingBlood, 2009
- Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra virusesExpert Opinion on Biological Therapy, 2009
- Cross-Reactive Human Immunodeficiency Virus Type 1-Neutralizing Human Monoclonal Antibody That Recognizes a Novel Conformational Epitope on gp41 and Lacks Reactivity against Self-AntigensJournal of Virology, 2008
- Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodiesProceedings of the National Academy of Sciences, 2007
- Cross-reactive HIV-1 neutralizing monoclonal antibodies selected by screening of an immune human phage library against an envelope glycoprotein (gp140) isolated from a patient (R2) with broadly HIV-1 neutralizing antibodiesVirology, 2007
- Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panningJournal of Immunological Methods, 2006
- Characterization and HIV-1 Fusion Inhibitory Properties of Monoclonal Fabs Obtained From a Human Non-immune Phage Library Selected Against Diverse Epitopes of the Ectodomain of HIV-1 gp41Journal of Molecular Biology, 2005
- Antibody neutralization and escape by HIV-1Nature, 2003
- Viral Persistence: HIV's Strategies of Immune System EvasionAnnual Review of Medicine, 2002